Detection and typing of human papillomavirus in cervical carcinomas in Russian women: A prognostic study

Cancer

Volumn 85, Issue 9, 1999, Pages 2011-2016

  Van Muyden, Ruud C P A ^a   Ter Harmsel, Bram W A ^a   Smedts, Frank M M ^a   Hermans, Jo ^b   Kuijpers, Johan C ^a   Raikhlin, Nathan T ^c   Petrov, Semyon ^d   Lebedev, Anatoly ^c   Ramaekers, Frans C S ^e   Trimbos, J Baptist ^b   Kleter, Bernhard ^a   Quint, Wim G V ^a  

^a Reinier de Graaf Gasthuis ^*  (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Cancer Research Center   (Russian Federation)

^d KAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Bcl 2; Cervical carcinoma; Human papillomavirus type; Ki 67 Ag; P53; Relapse risk; Survival; Tumor stage

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53; VIRUS DNA;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SQUAMOUS CELL CARCINOMA; USSR; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

ADULT; AGE DISTRIBUTION; FEMALE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; NEOPLASM STAGING; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RUSSIA; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 0033135789     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990501)85:9<2011::AID-CNCR19>3.0.CO;2-N     Document Type: Article

References (30)

1. Muñoz N, Bosch FX, de Sanjosé S, Tafur L, Izarzugaza I, Gili M, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case control study in Colombia and Spain. Int J Cancer 1992;52:743-9.
2. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1994;85:958-64.
3. Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer 1995;76:1888-901.
4. Felsenstein J. PHYLIP (Phylogenetic Iference Package) version 3.5c. Distributed by the author. Seattle: Department of Genetics, University of Washington.
5. Van Ranst M, Kaplan JB, Burk RD. Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations. J Gen Virol 1992;73:2653-60.
6. zur Hausen H. Papillomavirus infections: a major cause of human cancers. Biochim Biophys Acta 1996;1288:F55-F78.
7. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79:328-37.
8. Bergeron C, Barrasso R, Beaudenon S, Flamant P, Croissant O, Orth G. Human papillomavirus associated with cervical intraepithelial neoplasia. Am J Surg Pathol 1992;16:641-9.
9. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, et al. Persistence of type specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40.
10. Downey GP, Bavin PJ, Deery ARS, Crow J, Grifiths PD, Emery VC, et al. Relation between human papillomavirus type 16 and potential for progression of minor grade cervical disease. Lancet 1994;344:432-5.
11. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-8.
12. Remmink AJ, Walboomers JMM, Helmerhorst ThJM, Voorhorst FJ, Rozendaal L, Risse EK, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995;61:306-11.
13. Wheeler CM, Greer CE, Becker TM, Hunt WC, Anderson SM, Manos MM. Short-term fluctuations in the detection of cervical human papillomavirus DNA. Obstet Gynecol 1996;88:261-8.
14. Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ, Vousden KH. Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumors. Lancet 1992;339:1070-3.
15. Riou G, Favre M, Jeannel D, Bourhis J, Le Doussal V, Orth G. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet 1990;335:1171-4.
16. Higgins GD, Davy M, Roder D, Uzelin DM, Phillips GE, Burrell CJ. Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet 1991;338:910-3.
17. Nakagawa S, Yoshikawa H, Onda T, Kawana T, Iwamoto A, Taketani Y. Type of human papillomavirus is related to clinical features of cervical carcinoma. Cancer 1996;78:1935-41.
18. Walker J, Bloss JD, Liao SY, Berman M, Bergen S, Wilczynski SP. Human papillomavirus genotype as a prognostic indicator in carcinoma of the uterine cervix. Obstet Gynecol 1989;74:781-5.
19. Kurman RJ, Schiffman MH, Lancaster WD, Reid R, Jenson B, Temple GF, et al. Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression. Am J Obstet Gynecol 1988;159:293-6.
20. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, et al. International Biological Study on Cervical Cancer (IBSCC) Study Group. Prevalence if human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
21. FIGO staging of gynecologic cancers, cervical, and vulva. Int J Gynecol Cancer 1995;5:319.
22. Claas ECJ, Melchers WJG, van der Linden HC, Lindeman J, Quint WGV. Human papillomavirus detection in paraffin-embedded cervical carcinomas and metastases of the carcinomas by the polymerase chain reaction. Am J Pathol 1989; 135:703-9.
23. Kleter B, van Doorn LJ, ter Schegget J, Schrauwen L, van Krimpen K, Burger M, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998. In press.
24. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1987;239:487-91.
25. Saiki RK, Scarf S, Faloona F, Mullis KB, Horn GT, Erlich HA, et al. Enzymatic amplification of B-globin genomic sequences and restriction site analysis for diagnosis of sickle-cell annemia. Science 1985;230:1350-4.
26. ter Harmsel B, van Muyden R, Smedts F, Hermans J, Kuijpers J, Raikhlin N, et al. The significance of cell type and tumor growth markers in the prognosis of unscreened cervical cancer patients. Int J Gynecol Cancer 1998;8:336-44.
27. Matthews DE, Farewell VT. Using and understanding medical statistics. 3th revised edition. Basel: Karger, 1996.
28. Baay MFD, Quint WGV, Koudstaal J, Hollema H, Duk JM, Burger MPM, et al. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 1996;34:745-7.
29. Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G, Holm R, et al. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol 1996; 34:2095-2100.
30. Melchers W, van den Brule A, Walboomers J, de Bruin M, Burger M, Herbrink P, et al. Increased detection rate of human papillomavirus in cervical scrapes by the polymerase chain reaction as compared to modified FISH and Southern blot analysis. J Med Virol 1989;27:329-35.